Share this story
Close X
Switch to Desktop Site

Government should stay out of the medicine cabinet

(Read article summary)

Sarah Beth Glicksteen / Staff / File

(Read caption) A health care worker measures pills in Boston in the file photo. Guest blogger Bill Butos writes that new drug development center in the National Institutes of Health does too much to help commercial drug developers.

About these ads

The New York Times of January 22 reports that the Obama administration has created a “billion-dollar government drug development center to help create medicines” as part of the federally funded National Institutes of Health.

According to the article, its rationale is to undertake research leading to the commercial development of drugs that has mysteriously lagged in the U.S. The article makes no mention of the regulatory costs drug firms face. The moving force behind this new center is NIH Director Francis Collins, famously (and embarrassingly) associated as runner-up in the Human Genome Project to Craig Ventner’s privately funded effort.

The Times marvels at Collins’ “ability to conceive and create such a center in a few short months.” Yet his political connections apparently run quite deep. As Thomas McQuade reminds me, Bill Clinton arranged for a face-saving event for Collins in which the human genome “race” was declared a tie.


Page:   1   |   2

Follow Stories Like This
Get the Monitor stories you care about delivered to your inbox.